FGFR1 and lung adenocarcinoma: Amplification of the fibroblast growth factor receptor 1 gene (FGFR1) in NSCLC occurs in 22% of lung squamous cell carcinomas and 4% lung adenocarcinomas and correlates to poorer overall survival and shorter disease free survival [4–6].